tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (CLVLF)
OTHER OTC:CLVLF
US Market

Clinuvel Pharmaceuticals (CLVLF) Stock Forecast & Price Target

Compare
43 Followers
See the Price Targets and Ratings of:

CLVLF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Clinuvel
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLVLF Stock 12 Month Forecast

There Are No Analyst Ratings for CLVLF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CLVLF Financial Forecast

CLVLF Earnings Forecast

Next quarter’s earnings estimate for CLVLF is $0.21 with a range of $0.20 to $0.21. The previous quarter’s EPS was $0.31. CLVLF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CLVLF has Performed in-line its overall industry.
Next quarter’s earnings estimate for CLVLF is $0.21 with a range of $0.20 to $0.21. The previous quarter’s EPS was $0.31. CLVLF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CLVLF has Performed in-line its overall industry.

CLVLF Sales Forecast

Next quarter’s sales forecast for CLVLF is $26.38M with a range of $24.92M to $27.32M. The previous quarter’s sales results were $42.03M. CLVLF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CLVLF has Performed in-line its overall industry.
Next quarter’s sales forecast for CLVLF is $26.38M with a range of $24.92M to $27.32M. The previous quarter’s sales results were $42.03M. CLVLF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CLVLF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgans
$9.84
Buy
36.11%
Upside
Upgraded
11/11/25
Clinuvel Pharmaceuticals (CLVLF) was upgraded to a Buy Rating at Morgans
Canaccord Genuity Analyst forecast on CLVLF
Canaccord Genuity
Canaccord Genuity
$23.08
Buy
219.28%
Upside
Reiterated
10/03/25
Analysts Offer Insights on Healthcare Companies: Polynovo (Other OTC: CALZF) and Clinuvel Pharmaceuticals (Other OTC: CLVLF)
MA Financial Group Analyst forecast on CLVLF
MA Financial Group
MA Financial Group
$16.26
Buy
124.88%
Upside
Reiterated
08/29/25
Bell Potter Analyst forecast on CLVLF
Bell Potter
Bell Potter
$13.36
Buy
84.72%
Upside
Reiterated
08/29/25
Bell Potter Sticks to Their Buy Rating for Clinuvel Pharmaceuticals (CLVLF)
Jefferies Analyst forecast on CLVLF
Jefferies
Jefferies
$28.12
Buy
288.89%
Upside
Reiterated
07/18/25
Jefferies Sticks to Their Buy Rating for Clinuvel Pharmaceuticals (CLVLF)
Ord Minnett Analyst forecast on CLVLF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$15.89
Buy
119.72%
Upside
Reiterated
07/01/25
Ord Minnett Sticks to Their Buy Rating for Clinuvel Pharmaceuticals (CLVLF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgans
$9.84
Buy
36.11%
Upside
Upgraded
11/11/25
Clinuvel Pharmaceuticals (CLVLF) was upgraded to a Buy Rating at Morgans
Canaccord Genuity Analyst forecast on CLVLF
Canaccord Genuity
Canaccord Genuity
$23.08
Buy
219.28%
Upside
Reiterated
10/03/25
Analysts Offer Insights on Healthcare Companies: Polynovo (Other OTC: CALZF) and Clinuvel Pharmaceuticals (Other OTC: CLVLF)
MA Financial Group Analyst forecast on CLVLF
MA Financial Group
MA Financial Group
$16.26
Buy
124.88%
Upside
Reiterated
08/29/25
Bell Potter Analyst forecast on CLVLF
Bell Potter
Bell Potter
$13.36
Buy
84.72%
Upside
Reiterated
08/29/25
Bell Potter Sticks to Their Buy Rating for Clinuvel Pharmaceuticals (CLVLF)
Jefferies Analyst forecast on CLVLF
Jefferies
Jefferies
$28.12
Buy
288.89%
Upside
Reiterated
07/18/25
Jefferies Sticks to Their Buy Rating for Clinuvel Pharmaceuticals (CLVLF)
Ord Minnett Analyst forecast on CLVLF
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
$15.89
Buy
119.72%
Upside
Reiterated
07/01/25
Ord Minnett Sticks to Their Buy Rating for Clinuvel Pharmaceuticals (CLVLF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Clinuvel Pharmaceuticals

3 Months
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+1.70%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.70% per trade.
1 Year
OpenAI BiotechnologyTipRanks - OpenAI
Success Rate
1/2 ratings generated profit
50%
Average Return
+3.20%
reiterated a buy rating 4 months ago
Copying OpenAI Biotechnology's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.20% per trade.
2 Years
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+3.20%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +3.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLVLF Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
9
11
36
42
40
Buy
2
0
0
0
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
12
37
43
40
In the current month, CLVLF has received 40 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CLVLF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

CLVLF Stock Forecast FAQ

What is CLVLF’s average 12-month price target, according to analysts?
Currently, no data Available
What is CLVLF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CLVLF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CLVLF a Buy, Sell or Hold?
      Currently, no data Available
      What is Clinuvel Pharmaceuticals Limited’s price target?
      Currently, no data Available
      What do analysts say about Clinuvel Pharmaceuticals Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CLVLF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.